Why GlaxoSmithKline plc Is A Better Dividend Stock Than BP plc

A look at dividend sustainability and the growth prospects for GlaxoSmithKline plc (LON:GSK) and BP plc (LON:BP).

| More on:

The content of this article was relevant at the time of publishing. Circumstances change continuously and caution should therefore be exercised when relying upon any content contained within this article.

When investing, your capital is at risk. The value of your investments can go down as well as up and you may get back less than you put in.

Read More

The content of this article is provided for information purposes only and is not intended to be, nor does it constitute, any form of personal advice. Investments in a currency other than sterling are exposed to currency exchange risk. Currency exchange rates are constantly changing, which may affect the value of the investment in sterling terms. You could lose money in sterling even if the stock price rises in the currency of origin. Stocks listed on overseas exchanges may be subject to additional dealing and exchange rate charges, and may have other tax implications, and may not provide the same, or any, regulatory protection as in the UK.

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More.

At first glance, it may seem strange to suggest GlaxoSmithKline (LSE: GSK) is a better dividend stock than BP (LSE: BP), as GSK’s dividend yield of 5.7% is significantly lower than BP’s 6.6%. However, the best dividend stocks are not necessarily the highest yielding ones. A high yield may be tempting for income investors, but dividend sustainability and the potential for capital growth should be just as important for dividend investors.

In this article, we will take a look at what makes GSK a better dividend stock than BP.

Dividend Sustainability

GSK has better dividend sustainability. Its dividend cover in 2014 is 1.2x, whilst BP’s is 0.5x. But, whilst it is important to look at coverage ratios to evaluate the dividend sustainability of these stocks, a qualitative evaluation of the underlying fundamentals is just as important.

Should you invest £1,000 in Marks and Spencer right now?

When investing expert Mark Rogers has a stock tip, it can pay to listen. After all, the flagship Motley Fool Share Advisor newsletter he has run for nearly a decade has provided thousands of paying members with top stock recommendations from the UK and US markets. And right now, Mark thinks there are 6 standout stocks that investors should consider buying. Want to see if Marks and Spencer made the list?

See the 6 stocks

Although BP remains committed to maintaining its dividend even with lower oil prices, its operating cash flow in the near term will fail to cover its capital spending budget and its dividend payments. Operating cash flow in the first six months of 2015 had almost halved to $8.1 billion, from $16.1 billion last year. BP is selling assets and taking on more debt to maintain the dividend, but this is not a sustainable strategy in the long term. Investors and analysts seem to expect oil prices will bounce back to above $80 within a few years, but there are growing concerns that this seems to be becoming less likely.

GSK’s revenue base is far more stable, as the demand for drugs are non-cyclical. The non-cyclical nature of the healthcare sector means that GSK can reliably generate stable earnings and cash flow to pay its dividends. Although the loss of patent expiration does lead to intense competition from generic manufacturers, the volatility of GSK’s earnings is much lower than it is for BP. This is because the overwhelming majority of GSK’s earnings is derived from products that still enjoy patent protection or products that rely more heavily on its branding, such as its consumer healthcare business.

Growth

Both companies have seen earnings decline in recent quarters, but it seems that GSK will bounce back more quickly. GSK, which has seen the expiry of blockbuster drugs lead to shrinking revenues, benefits from a strong pipeline of 40 new drugs that should soon allow the company to return to growth. Its management is confident that earnings per share will grow in the double digits on a constant currency basis in 2016. GSK’s dividend has been fixed at 80 pence annually until 2018, but a return to growth is likely to lead to an uprating in GSK’s shares long before that.

BP, whose earnings depend heavily on the oil price, is likely to freeze its quarterly dividend at $0.10 per share, unless the oil price recovers to at least $80 per barrel for a sustained period of time. With production from Iran flowing back into the international market, the prospects of a sustained rise in oil prices just seems unlikely. And, if the price of Brent crude oil stays near today’s level of around $50 per barrel, BP would need to consider cutting its dividend to conserve cash. If that happens, shares in BP have a long way to fall.

Although GSK is far from being a perfect stock, its stronger dividend sustainability and the greater visibility over its earnings and cash flows justify its lower dividend yield.

Should you buy Marks and Spencer now?

Don’t make any big decisions yet.

Because Mark Rogers — The Motley Fool UK’s Director of Investing — has revealed 5 Shares for the Future of Energy.

And he believes they could bring spectacular returns over the next decade.

Since the war in Ukraine, nations everywhere are scrambling for energy independence, he says. Meanwhile, they’re hellbent on achieving net zero emissions. No guarantees, but history shows...

When such enormous changes hit a big industry, informed investors can potentially get rich.

So, with his new report, Mark’s aiming to put more investors in this enviable position.

Click the button below to find out how you can get your hands on the full report now, and as a thank you for your interest, we’ll send you one of the five picks — absolutely free!

Grab your FREE Energy recommendation now

Should you invest, the value of your investment may rise or fall and your capital is at risk. Before investing, your individual circumstances should be assessed. Consider taking independent financial advice.

Jack Tang has no position in any shares mentioned. The Motley Fool UK has recommended GlaxoSmithKline. We Fools don't all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors.

More on Investing Articles

Investing Articles

Just released: our 3 top small-cap stocks to consider buying in April [PREMIUM PICKS]

Small-cap shares tend to be more volatile than larger companies, so we suggest investors should look to build up a…

Read more »

Investing Articles

Here’s why Tesla stock just rocketed 22.7%! Is it time to buy?

This writer wonders whether the news that sent Tesla stock soaring yesterday is a true gamechanger for the electric vehicle…

Read more »

Investing Articles

2 quality UK stocks to consider buying as share prices rally

With UK stocks moving higher, it might look as though investors with cash on hand have missed their chance. But…

Read more »

Investing Articles

How much £10,000 invested in Lloyds shares is forecast to be worth in 12 months

Harvey Jones is looking past today's stock market volatility to see where Lloyds shares may stand in a year's time.…

Read more »

Investing Articles

How Warren Buffett stays ahead of the stock market

When share prices fall, everyone suddenly wants to be like Warren Buffett. But what’s the secret to the Berkshire Hathaway…

Read more »

Investing Articles

Cheap UK dividend shares to consider buying right now

We're only just past the first quarter of 2025, but it already looks like the year could be another good…

Read more »

Young Asian woman with head in hands at her desk
Investing Articles

What the heck is going on with the Barclays share price now?

The Barclays share price surged 25% as the market open on 10 April. Once again, the volatility’s been driven by…

Read more »

Middle-aged white man pulling an aggrieved face while looking at a screen
Investing Articles

What the devil’s going on with the HSBC share price?

The HSBC share price has actually been less volatile than some of its peers, despite its Chinese operations suggesting it’s…

Read more »